T-regulatory Cells in ALS

NCT04055623 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

ALS (Amyotrophic Lateral Sclerosis)

Interventions

BIOLOGICAL: Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections
OTHER: Monthly placebo infusions + 3 times per week placebo injections
BIOLOGICAL: Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]
[object Object]
[object Object]